Auricular acupressure for myopia prevention and control in children and its effect on choroid and retina: a randomized controlled trial protocol
Background Nowadays, because of the increasing incidence, the prevention and control of myopia has become an urgent issue. In China, auricular acupressure has been commonly used in the clinical treatment of myopia in children, but the exact effectiveness remains unproven. The purpose of this trial i...
Saved in:
Published in | Current controlled trials in cardiovascular medicine Vol. 22; no. 1; pp. 387 - 8 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
07.06.2021
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1745-6215 1745-6215 |
DOI | 10.1186/s13063-021-05334-1 |
Cover
Summary: | Background
Nowadays, because of the increasing incidence, the prevention and control of myopia has become an urgent issue. In China, auricular acupressure has been commonly used in the clinical treatment of myopia in children, but the exact effectiveness remains unproven. The purpose of this trial is to observe the efficacy of auricular acupressure in myopia prevention and control, as well as its effect on the choroidal and retinal thickness.
Method/design
A total of 480 subjects at 8–9 years old will be randomized in a 1:1 ratio to an intervention group versus a control group. The intervention group will receive auricular acupressure for 12 months, while the control group will be taken as a blank control. The primary and secondary outcomes will be measured at baseline, and again at 3, 6, 9, and 12 months after recruitment. The myopia incidence (spherical equivalent ≤ − 0.50 D) and the mean change of spherical equivalent will be taken as the primary variables; the secondary outcome measures include axial length, uncorrected visual acuity, and choroidal and retinal thickness.
Discussion
This trial aims to evaluate the effectiveness of auricular acupressure for myopia prevention and control with objective evidence and to preliminarily explore the plausible mechanism and provide reference for adopting this approach to retard the onset and control the progression of myopia.
Trial registration
Chinese Clinical Trial Registry
ChiCTR2000038456
. Registered on September 23, 2020. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Undefined-1 content type line 23 |
ISSN: | 1745-6215 1745-6215 |
DOI: | 10.1186/s13063-021-05334-1 |